Skip to main content

Table 3 Effect of Piperonal on plasma glucose, insulin and insulin resistance in normal and experimental obese rats

From: Antiobesity potential of Piperonal: promising modulation of body composition, lipid profiles and obesogenic marker expression in HFD-induced obese rats

Groups Glucose (mg dl−1) Insulin (μU ml−1) Insulin resistance
ND control 90.9±7.1 6.0±0.2 3.6±.0.4
HFD Control 150.1±9.7a* 27.2±0.4 a* 6.3±0.2a*
HFD + Orlistat 5 mg/kg b.wt 103.1±4.9 b* 15.8±1.4 b* 4.5±0.6 b*
HFD + Piperonal 20 mg/kg b.wt 140.7±7.2 24.3.7±0.44 6.0±0.2
HFD + Piperonal 30 mg/kg b.wt 131.7±2.3 b* 19.7.4±0.5 b* 5.1±0.2 b*
HFD + Piperonal 40 mg/kg b.wt 101.5±5.5 b* 17.9±0.24 b* 4.8±0.3 b*
  1. Values are mean ± SD, n = 6
  2. Values are statistically significant at *p < 0.05
  3. aSignificantly different from normal control
  4. bSignificantly different from HFD control